Clinical quality management in rheumatoid arthritis: Putting theory into practice

Rheumatology

Volumn 39, Issue 5, 2000, Pages 542-549

  Uitz, E ^a   Fransen, J ^a   Langenegger, T ^a   Stucki, G ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Case studies; Damage; Disability; Disease activity; Outcome; Quality management; Rheumatoid arthritis; Rheumatology

Indexed keywords

ANTIRHEUMATIC AGENT; CHLOROQUINE; CYCLOSPORIN; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE ACTIVITY; FEEDBACK SYSTEM; FEMALE; HEALTH CARE QUALITY; HUMAN; JOINT RADIOGRAPHY; MEDICAL DECISION MAKING; NAUSEA; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RASH; RHEUMATOID ARTHRITIS; SWITZERLAND;

EID: 0034088598     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.5.542     Document Type: Article

References (34)

1. Stucki G, Sangha O. Clinical Quality Management: putting the pieces together. Arthritis Care Res 1996;9:405-12.
2. Deyo RA, Patrick DL, Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989;27(Suppl. 3):S254-68.
3. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology ad hoc committee on clinical guidelines. Arthritis Rheum 1996;39:713-22.
4. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drugs-based treatment strategies. Arthritis Rheum 1996;39:616-22.
5. Abu-Skakra M, Toker R, Flusser D et al. Clinical and radiographic outcomes of rheumatoid arthritis patients not treated with disease-modifying drugs. Arthritis Rheum 1998;41:1190-5.
6. Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 1999;26:717-9.
7. Stucki G, Langenegger T. Management of rheumatoid arthritis. Curr Opin Rheumatol 1997;9:229-35.
8. Van Gestel AM, Van Riel PL. Evaluation of early rheumatoid arthritis disease activity and outcome. Baill Clin Rheumatol 1997;11:49-63.
9. Boers M, Tugwell P, Felson DT et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol 1994;41:86-9.
10. Van Gestel AM, Haagsma CJ, Van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998;41:1845 50.
11. Prevoo MLL, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LBA, Van Riel PLCM. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
12. Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 1998;25:2094-107.
13. Stucki G, Liang MH, Stucki S, Briihlmann P, Michel BA. A self-administered Rheumatoid Arthritis Disease Activity Index (RADAI) for epidemiological research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795-8.
14. Fries JF, Spitz P, Kraines RG, Holman HR, Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
15. Brühlmann P, Stucki G, Michel BA. Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with Rheumatoid Arthritis. J Rheumatol 1994;21:1245 9.
16. Redelmeier DA, Lorig K. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology. Arch Intern Med 1993;153:1337-42.
17. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Häuselmann HJ, Caravatti M, Seifert B et al. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial. Br J Rheumatol 1998;37: 1110-7.
19. Van Leeuwen MA, Van Rijswijk MH, Sluiter WJ et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20 7.
20. Van Riel PL, Van Gestel AM, Van de Putte LB. Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol 1996; 35(Suppl. 2):4-7.
21. Fries JF, Williams CA, Morfeld D, Singh G, Sibley J. Reduction of long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies. Arthritis Rheum 1996;39:616 22.
22. Katz JN, Solomon D. Differences between generalists and specialists (Editorial). Arthritis Care Res 1997;10:161-2.
23. Kasdan ML, June L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993;16:1233-5.
24. Sany J, Anaya JM, Canovas F et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 1993;20:1129-32.
25. Van Gestel AM, Haagsma CJ, Furst DE, Van Riel PLCM. Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs). Baill Clin Rheumatol 1997:11:65-82.
26. O'Dell JR, Haire CE, Erikson N et al Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
27. Hawley DJ, Wolfe F. Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1.522 patients. J Rheumatol 1991;18:1552-7.
28. Stucki G, Michel BA. How to measure improvement: rules and fallacies. Rheumatol Europe 1995;24(Suppl. 2): 107-11.
29. Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997;24:1477 85.
30. Deyo RA, Carter WB, Strategies for improving and expanding the application of health status measures in clinical settings. A researcher developer viewpoint. Med Care 1992;30(Suppl. 5):MS176-86.
31. Wolfe F, Pincus T. Standard self-report questionnaires in routine clinical and research practice - an opportunity for patients and rheumatologists (Editorial). J Rheumatol 1991:18:643-6.
32. Patrick D. Strategies for improving and expanding the application of health status measures in clinical settings. Med Care 1992;30(Suppl. 5):MS198 201.
33. Stucki G. Specialist management: needs and benefits. Baill Clin Rheumatol 1997;11:97-107.
34. Criswell LA, Such CL, Yelin EH, Differences in the use of second-line agents and prednisone for treatment of rheumatoid arthritis by rheumatologists and non-rheumatologists. J Rheumatol 1997;24:2283 90.